Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 104-117

  Bowenkamp, Kathryn E ^a   Lapchak, Paul A ^c   Hoffer, Barry J ^a   Miller, Paul J ^c   Bickford, Paula C ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIC FACTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 17744408450     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6436     Document Type: Article

References (44)

1. Adams R. D., Victor M. Degenerative diseases of the nervous system. Principles of Neurology. 1993;McGraw-Hill, New York.
2. Andén N. E., Fuxe K., Hamberger B., Hökfelt T. A quantitative study on the nigro-striatal dopamine neuron system in the rat. Acta Physiol. Scand. 67:1996;306-312.
3. Bernheimer H., Birkmayer W., Hornykiewcz O., Jellinger K., Seitelberger R. Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20:1973;415-455.
4. Bowenkamp K. E., David D., Lapchak P. A., Henry M. A., Granholm A. C., Hoffer B. J., Mahalik T. J. 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. Exp. Brain Res. 111:1996;1-7.
5. Bowenkamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., Granholm A-C. E. Glial cell-line derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489.
6. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
7. Dunnett S. B., Björklund A., Stenevi U., Iversen S. D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions. Brain Res. 229:1981;457-470.
8. Farooqui S. M., Brock J. W., Onaivi E. S., Hamdi A., Prasad C. Differential modulation of dopaminergic systems in the rat brain by dietary protein. Neurochem. Res. 19:1994;167-176.
9. Fibiger H. C., Zis A. P., McGeer E. G. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: Similarities to the lateral hypothalamic syndrome. Brain. Res. 55:1973;135-148.
10. Geffen L. B., Jessel T. M., Cuello A. C., Iversen L. L. Release of dopamine from dendrites in rat substantia nigra. Nature. 260:1976;258-260.
11. Hedreen J. C., Chalmers J. P. Neuronal degeneration in rat brain induced by 6-hydroxydopamine: A histological and biochemical study. Brain Res. 47:1972;1-36.
12. Heikkila R. E., Hess A., Duvoisin R. C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
13. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L-F. H., Gerhardt G. A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
14. Hornykiewicz O., Kish S. J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1986;19-34.
15. Hudson J., Granholm A-C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P., Leela N. S., Mackerlova L., Lile J. D., Collins F., Hoffer B. J. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Br. Res. Bull. 36:1995;425-432.
16. Jeon B. S., Jackson-Lewis V., Burke R. E. 6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death. Neurodegeneration. 4:1995;131-137.
17. Jonsson G. Björklund A., Hökfelt T. Handbook of Chemical Neuroanatomy, Vol. 1: Methods in Chemical Neuroanatomy. 1983;463-507 Elsevier, Amsterdam.
18. 3. Brain Res. 267:1983;301-311.
19. Lapchak P. A., Araujo D. M., Gash D. M., Hilt D., Hoffer B. J., Collins F. Glial cell line-derived neurotrophic factor (GDNF): Pharmacological activities and application to the treatment of Parkinson's disease. Exp. Neurol. 1996.
20. Lapchak P. A. Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. Rev. Neurosci. 1996.
21. Leenders K. L., Salmon E. P., Tyrrell P., Perani D., Brooks D. J., Sager H., Jones T., Marsden D., Franchowiak R. S. J. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteers and in patients with Parkinson's disease. Arch. Neurol. 47:1993;1290-1298.
22. Lees G. J., Kydd R. R., Wright J. J. Relationship between sensorimotor neglect and the specificity, degree, and locus of mesotelencephalic dopaminergic cell loss following 6-hydroxydopamine. Psychopharmacology. 85:1985;115-122.
23. Lin L-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
24. Ljunberg T., Ungerstedt U. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain. Exp. Neurol. 53:1976;585-600.
25. Lyon M., Halpern M., Mintz E. The significance of the mesencephalon for coordinated feeding behavior. Acta Neurol. Scand. 44:1968;323-346.
26. 3. Eur. J. Pharmacol. 156:1988;331-340.
27. Marshall J. F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control. Brain Res. 177:1979;311-324.
28. Marshall J. F., Teitelbaum P. Further analysis of sensory inattention following lateral hypothalamic damage in rats. J. Comp. Physiol. Psychol. 86:1974;375-395.
29. Marshall J. F., Richardson J. S., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J. Comp. Physiol. Psychol. 87:1974;808-830.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
31. Robertson G. S., Robertson H. A. Evidence thatL. J. Neurosci. 9:1989;3326-3331.
32. Robertson G. S., Robertson H. A. Evidence that the substantia nigra is a site of action forL. Neurosci. Lett. 89:1988;204-208.
33. Robertson G. S., Robertson H. A. D1 and D2 dopamine agonist synergism: Separate sites of action. Trends Pharmacol. Sci. 8:1987;295-299.
34. Robertson G. S., Robertson H. A. CombinedL. Clin. Neuropharmacol. 10:1987;84-87.
35. Sauer H., Rosenblad C., Björklund A. GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine-lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
36. Schallert T., Whishaw I. Two types of aphagia and two types of sensorimotor impairment after lateral hypothalamic lesions: Observations in normal weight, dieted, and fattened rats. J. Comp. Physiol. Psychol. 92:1978;720-741.
37. Schmidt R. A., Björklund A., Stenevi U. Intracerebral grafting of dissociated CNS tissue suspensions: A new approach for neuronal transplantation to deep brain sites. Brain. Res. 218:1981;347-356.
38. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta Physiol. Scand. Suppl. 367:1971;49-68.
39. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;69-93.
40. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;95-122.
41. Walkinshaw G., Waters C. M. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 63:1994;975-987.
42. West M. J. New stereological methods for counting neurons. Neurobiol. Aging. 14:1993;275-285.
43. White N. M. Control of sensorimotor function by dopaminergic nigrostriatal neurons: Influence on eating and drinking. Neurosci. Biobehav. Rev. 10:1986;15-36.
44. Zigmond M. J., Stricker E. M. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science. 177:1972;1211-1213.